In Vivo Screen Identifies Liver X Receptor Alpha Agonism Potentiates Sorafenib Killing of Hepatocellular Carcinoma
Gastro Hep Adv
.
2022;1(5):905-908.
doi: 10.1016/j.gastha.2022.05.014.
Epub 2022 Jun 1.
Authors
A M Vázquez Salgado
1
,
M E Preziosi
1
,
D Yin
1
,
A Holczbauer
1
,
A M Zahm
2
,
N Erez
1
,
J Kieckhaefer
1
,
D Ackerman
3
,
T P Gade
3
,
K H Kaestner
2
,
K J Wangensteen
1
2
Affiliations
1
Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
2
Department of Genetics, University of Pennsylvania, Philadelphia, Pennsylvania.
3
Penn Image-Guided Interventions Laboratory, Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania.
PMID:
36117551
PMCID:
PMC9481113
DOI:
10.1016/j.gastha.2022.05.014
No abstract available
Grants and funding
K01 DK102868/DK/NIDDK NIH HHS/United States
K08 DK106478/DK/NIDDK NIH HHS/United States
P30 DK050306/DK/NIDDK NIH HHS/United States
R01 DK102667/DK/NIDDK NIH HHS/United States